Aura Biosciences, Inc. - Common Stock (AURA)

Historical Holders from Q4 2021 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
AURA on Nasdaq
Shares outstanding
61,778,278
Price per share
$5.44
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
51,649,515
Holdings value
$319,192,253
% of all portfolios
0%
Share change
+1,014,751
Value change
+$6,254,101
Average buys %
+0%
Average sells %
-0%
Number of holders
105
Price from insider filings
$5.42
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Aura Biosciences, Inc. - Common Stock (AURA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Matrix Capital Management Company, LP 11% $38,214,242 6,922,870 Matrix Capital Management Company LP 16 May 2025
SUVRETTA CAPITAL MANAGEMENT, LLC 7.6% +25% $30,091,360 +$10,524,518 4,701,775 +54% Suvretta Capital Management, LLC 30 Jun 2025
BlackRock, Inc. 5.4% +10% $20,617,314 +$1,842,342 3,336,027 +9.8% BlackRock, Inc. 30 Sep 2025
Long Focus Capital Management, LLC 6.6% +75% $18,324,093 +$4,481,180 3,319,582 +32% LONG FOCUS CAPITAL MANAGEMENT, LLC 31 Mar 2025
Frazier Life Sciences Public Fund, L.P. 5% -49% $19,926,720 -$20,493,619 3,113,550 -51% Frazier Life Sciences Public Fund, L.P. 30 Jun 2025
As of 30 Sep 2025, Aura Biosciences, Inc. - Common Stock (AURA) has 105 institutional shareholders filing 13F forms. They hold 51,649,515 shares of 61,778,278 outstanding shares (84%) .

Top 25 institutional shareholders own 79% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
Matrix Capital Management Company, LP 11% 6,922,870 0% 40% $42,783,337
Frazier Life Sciences Management, L.P. 8.3% 5,100,000 0% 0.94% $31,518,000
ADAGE CAPITAL PARTNERS GP, L.L.C. 7.9% 4,881,125 0% 0.05% $30,165,353
Long Focus Capital Management, LLC 7.5% 4,619,582 0% 1.7% $28,549,017
SUVRETTA CAPITAL MANAGEMENT, LLC 7.1% 4,372,884 0% 0.82% $27,024,423
BlackRock, Inc. 5.5% 3,405,477 +9.8% 0% $21,045,849
Medicxi Ventures Management (Jersey) Ltd 4.9% 3,039,892 0% 2.5% $18,786,533
VANGUARD GROUP INC 4.7% 2,890,503 +17% 0% $17,863,309
FRANKLIN RESOURCES INC 3.6% 2,198,915 -6.1% 0% $13,589,295
Nantahala Capital Management, LLC 3.4% 2,117,697 0% 0.81% $13,087,367
LEVIN CAPITAL STRATEGIES, L.P. 2.6% 1,627,274 +8.8% 0.92% $10,056,553
GEODE CAPITAL MANAGEMENT, LLC 2% 1,257,947 +35% 0% $7,775,353
UBS Group AG 1.5% 896,811 +0.65% 0% $5,542,292
STATE STREET CORP 1.4% 878,871 +2.6% 0% $5,431,423
Regency Capital Management Inc.\DE 0.99% 612,689 -8% 1.8% $3,786,418
ACORN CAPITAL ADVISORS, LLC 0.96% 595,744 0% 1.9% $3,681,698
SAMSARA BIOCAPITAL, LLC 0.95% 584,849 -42% 0.47% $3,614,367
B Group, Inc. 0.93% 572,576 0% 3.4% $3,538,520
Decheng Capital LLC 0.83% 515,555 0% 0.56% $3,186,130
DIMENSIONAL FUND ADVISORS LP 0.8% 497,275 +9% 0% $3,073,114
PRICE T ROWE ASSOCIATES INC /MD/ 0.78% 481,231 -4.7% 0% $2,975,000
NORTHERN TRUST CORP 0.7% 433,641 +17% 0% $2,679,902
Caligan Partners LP 0.37% 227,174 +14% 0.19% $1,403,935
GOLDMAN SACHS GROUP INC 0.32% 194,943 -8.2% 0% $1,204,748
MILLENNIUM MANAGEMENT LLC 0.3% 185,221 +49% 0% $1,144,666

Institutional Holders of Aura Biosciences, Inc. - Common Stock (AURA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 88,422 $478,500 -$391,108 $5.44 4
2025 Q3 51,649,515 $319,192,253 +$6,254,101 $6.18 105
2025 Q2 50,616,053 $316,863,119 +$67,408,487 $6.26 102
2025 Q1 39,264,901 $230,096,030 -$11,860,142 $5.86 91
2024 Q4 39,449,434 $324,276,778 +$16,157,250 $8.22 93
2024 Q3 36,866,668 $329,191,609 -$25,783,402 $8.91 81
2024 Q2 39,765,227 $300,437,451 +$3,314,060 $7.56 75
2024 Q1 39,115,323 $307,072,789 +$16,222,241 $7.85 77
2023 Q4 36,998,812 $327,811,496 +$89,731,106 $8.86 71
2023 Q3 26,323,010 $236,119,190 -$5,574,466 $8.97 62
2023 Q2 27,066,492 $334,426,517 +$24,980,886 $12.35 59
2023 Q1 25,069,599 $232,645,346 +$10,922,124 $9.28 57
2022 Q4 23,806,818 $250,037,016 +$78,469,205 $10.50 49
2022 Q3 16,317,002 $295,663,462 +$9,714,465 $18.12 43
2022 Q2 15,793,428 $223,796,376 +$29,644,466 $14.17 42
2022 Q1 13,702,730 $298,756,000 +$9,092,301 $22.00 34
2021 Q4 13,081,587 $220,131,000 +$220,131,000 $16.98 32